We were pleased to contribute to the Nanoparticle Formulation Symposium in London as an invited speaker, sharing insights into current and emerging approaches in nanoparticle development.
A Great Conversation on the Austrian Patent Office Podcast
We would like to thank the team at the Austrian Patent Office, and in particular Julia Zach, for the kind invitation to participate in the podcast and for the engaging and insightful conversation.
We recently had the pleasure of welcoming Prof. Bernhard Klausgraber from IMC Krems University of Applied Sciences to NovoArc GmbH. Prof. Klausgraber is the academic supervisor of our intern Ema Doneva, who is currently completing her Practical Training Semester with us.
We were pleased to attend CPHI Frankfurt, connecting with stakeholders across the pharmaceutical ecosystem, from drug development and formulation to manufacturing and supply chain solutions.
Biotech Austria Summit, a key platform for connecting startups, technology providers, investors, and industry stakeholders across the Austrian biotechnology ecosystem.
What began as a scientific pursuit has evolved into a robust technology platform grounded on archaeal tetraether lipids produced through our proprietary, patented processes.
Austria’s Biotech Future in Focus: NovoArc Hosts Federal Leaders
NovoArc GmbH had the honor of welcoming Federal Minister Dr. Wolfgang Hattmannsdorfer, Bundesvorsitzende der Jungen Wirtschaft Bettina Dorfer-Pauschenwein, and delegations from the Federal Ministry for Economic Affairs and Energy and the Austrian Federal Economic Chamber to NovoArc GmbH.
We are excited to announce the start of our Lipidosa Project in collaboration with Joanneum Graz, running from July 2025 to June 2027, focused on the pharmacological characterization of tetraetherlipid formulations for oral administration.
We use cookies on our website. They help us to improve this website and the user experience (tracking cookies). You can decide for yourself whether you want to allow them.
